Other members of the team
Gregory Wagner, Ph.D. DABT
Sr. Vice President of pre-Clinical Development at Resverlogix, Inc. and former VP of pre-Clinical Development at Galileo Pharmaceuticals.
Bill Fitch, Ph.D.
President of PosNeg Consulting, and a former Study Leader of DMPK at Roche Pharmaceuticals.
Jerry Shen, Ph.D.
Vice President of Biology at Lead Therapeutics, Inc. and former co-founder and Vice President of research at Applied Biomics
Bob Ings, Ph.D.
President of RMI Pharmacokinetics, and former Vice President of DMPK at Roche Pharmaceuticals.
Frank Xie Ph.D.
Predient of Bayside Biosciences